411 related articles for article (PubMed ID: 28285521)
1. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.
Favrot L; Lajiness DH; Ronning DR
J Biol Chem; 2014 Sep; 289(36):25031-40. PubMed ID: 25028518
[TBL] [Abstract][Full Text] [Related]
3. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
Ronning DR; Klabunde T; Besra GS; Vissa VD; Belisle JT; Sacchettini JC
Nat Struct Biol; 2000 Feb; 7(2):141-6. PubMed ID: 10655617
[TBL] [Abstract][Full Text] [Related]
6. Mycolyltransferase from
Goins CM; Dajnowicz S; Smith MD; Parks JM; Ronning DR
J Biol Chem; 2018 Mar; 293(10):3651-3662. PubMed ID: 29352107
[No Abstract] [Full Text] [Related]
7. Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.
Ibrahim DA; Boucau J; Lajiness DH; Veleti SK; Trabbic KR; Adams SS; Ronning DR; Sucheck SJ
Bioconjug Chem; 2012 Dec; 23(12):2403-16. PubMed ID: 23190459
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen.
Favrot L; Grzegorzewicz AE; Lajiness DH; Marvin RK; Boucau J; Isailovic D; Jackson M; Ronning DR
Nat Commun; 2013; 4():2748. PubMed ID: 24193546
[TBL] [Abstract][Full Text] [Related]
9. A Screen for Protein-Protein Interactions in Live Mycobacteria Reveals a Functional Link between the Virulence-Associated Lipid Transporter LprG and the Mycolyltransferase Antigen 85A.
Touchette MH; Van Vlack ER; Bai L; Kim J; Cognetta AB; Previti ML; Backus KM; Martin DW; Cravatt BF; Seeliger JC
ACS Infect Dis; 2017 May; 3(5):336-348. PubMed ID: 28276676
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the substrate binding mechanism of novel ArgA from Mycobacterium tuberculosis.
Das U; Singh E; Dharavath S; Tiruttani Subhramanyam UK; Pal RK; Vijayan R; Menon S; Kumar S; Gourinath S; Srinivasan A
Int J Biol Macromol; 2019 Mar; 125():970-978. PubMed ID: 30576731
[TBL] [Abstract][Full Text] [Related]
11. Weak spots inhibition in the
Adewumi AT; Elrashedy A; Soremekun OS; Ajadi MB; Soliman MES
J Biomol Struct Dyn; 2022 Apr; 40(7):2934-2954. PubMed ID: 33155529
[No Abstract] [Full Text] [Related]
12. Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall.
Gobec S; Plantan I; Mravljak J; Wilson RA; Besra GS; Kikelj D
Bioorg Med Chem Lett; 2004 Jul; 14(13):3559-62. PubMed ID: 15177473
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Mycobacterium tuberculosis transpeptidase Ldt
de Munnik M; Lohans CT; Lang PA; Langley GW; Malla TR; Tumber A; Schofield CJ; Brem J
Chem Commun (Camb); 2019 Aug; 55(69):10214-10217. PubMed ID: 31380528
[TBL] [Abstract][Full Text] [Related]
14. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity.
Ronning DR; Vissa V; Besra GS; Belisle JT; Sacchettini JC
J Biol Chem; 2004 Aug; 279(35):36771-7. PubMed ID: 15192106
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the toxin Msmeg_6760, the structural homolog of Mycobacterium tuberculosis Rv2035, a novel type II toxin involved in the hypoxic response.
Bajaj RA; Arbing MA; Shin A; Cascio D; Miallau L
Acta Crystallogr F Struct Biol Commun; 2016 Dec; 72(Pt 12):863-869. PubMed ID: 27917833
[TBL] [Abstract][Full Text] [Related]
17. The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.
Backus KM; Dolan MA; Barry CS; Joe M; McPhie P; Boshoff HI; Lowary TL; Davis BG; Barry CE
J Biol Chem; 2014 Sep; 289(36):25041-53. PubMed ID: 25028517
[TBL] [Abstract][Full Text] [Related]
18. Structural studies on Mycobacterium tuberculosis HddA enzyme using small angle X-ray scattering and dynamics simulation techniques.
Karan S; Behl A; Sagar A; Bandyopadhyay A; Saxena AK
Int J Biol Macromol; 2021 Feb; 171():28-36. PubMed ID: 33412198
[TBL] [Abstract][Full Text] [Related]
19. Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity.
Petrella S; Capton E; Raynal B; Giffard C; Thureau A; Bonneté F; Alzari PM; Aubry A; Mayer C
Structure; 2019 Apr; 27(4):579-589.e5. PubMed ID: 30744994
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic snapshots of sulfur insertion by lipoyl synthase.
McLaughlin MI; Lanz ND; Goldman PJ; Lee KH; Booker SJ; Drennan CL
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9446-50. PubMed ID: 27506792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
